| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/04/2007 | EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 07/04/2007 | EP1802580A2 Pyridine derivatives |
| 07/04/2007 | EP1802578A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 07/04/2007 | EP1802575A1 Polymorph of n,n-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
| 07/04/2007 | EP1802572A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 07/04/2007 | EP1802372A2 Cgrp receptor antagonists |
| 07/04/2007 | EP1802307A1 Pyrrolidine derivatives as histamine receptors ligands |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
| 07/04/2007 | EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces |
| 07/04/2007 | EP1375496B1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 07/04/2007 | EP1260512B1 Novel cyclic amide derivatives |
| 07/04/2007 | EP0977750B1 Farnesyltransferase inhibiting quinazolinones |
| 07/04/2007 | CN1993359A Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/04/2007 | CN1993357A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 07/04/2007 | CN1993353A Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 07/04/2007 | CN1993352A Piperazine derivatives with CCR3 inhibiting activity |
| 07/04/2007 | CN1993351A Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 07/04/2007 | CN1993350A Salt of benzimidazole derivative with amine, and process for producing the same |
| 07/04/2007 | CN1993349A Quinazoline derivatives as ERBB receptor tyrosine kinases |
| 07/04/2007 | CN1993348A 钾通道抑制剂 Potassium channel inhibitors |
| 07/04/2007 | CN1993347A 钾通道抑制剂 Potassium channel inhibitors |
| 07/04/2007 | CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 07/04/2007 | CN1993339A Aromatic compounds |
| 07/04/2007 | CN1993331A N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 07/04/2007 | CN1993329A Quinoline derivatives as neurokinin receptor antagonists |
| 07/04/2007 | CN1993325A Piperidine derivatives as histamine h3 receptor ligands |
| 07/04/2007 | CN1993324A 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 07/04/2007 | CN1993321A 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
| 07/04/2007 | CN1993128A N-substituted piperidines and their use as pharmaceuticals |
| 07/04/2007 | CN1993124A Substituted pyrazoles, compositions containing such compounds and methods of use |
| 07/04/2007 | CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor |
| 07/04/2007 | CN1990473A Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof |
| 07/04/2007 | CN1990471A Mch antagonists and their use in the treatment of obesity |
| 07/04/2007 | CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1324028C Variolin derivatives as anti-cancer agents |
| 07/04/2007 | CN1324023C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 07/04/2007 | CN1324022C Inhibitors of tyrosine kinases |
| 07/04/2007 | CN1324018C Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 07/04/2007 | CN1324015C Pyridine and pyrimidine derivatives |
| 07/04/2007 | CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors |
| 07/04/2007 | CN1324012C TNF-alpha prodn. inhibitors |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/03/2007 | US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238720 Pharmaceutical use of N-carbamoylazole derivatives |
| 07/03/2007 | US7238714 Analgesics; antiinflammatory agents; antiarthritic agents |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238712 Indole-type derivatives as inhibitors of p38 kinase |
| 07/03/2007 | US7238710 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/03/2007 | US7238698 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis. |
| 07/03/2007 | US7238697 Insecticides for crops |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders |
| 07/03/2007 | US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 07/03/2007 | US7238681 2-Methylene-18,19-dinor-1α-hydroxy-homopregnacalciferol and its uses |
| 07/03/2007 | CA2273959C Helium-neon excitable reticulocyte dyes derivable from halolepidines |
| 06/28/2007 | WO2007073303A2 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 06/28/2007 | WO2007073301A1 Benzoimidazole derivatives as prodrugs of proton pump inhibitors |
| 06/28/2007 | WO2007073300A1 Gaba-b receptor modulators |
| 06/28/2007 | WO2007073283A1 Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis |
| 06/28/2007 | WO2007072999A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 06/28/2007 | WO2007072782A1 Carboxylic acid derivative or salt thereof |
| 06/28/2007 | WO2007072150A2 Piperidine derivatives |
| 06/28/2007 | WO2007072093A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | WO2007072092A2 New phenanthridine derivatives as bradykinin antagonists |
| 06/28/2007 | WO2007072080A2 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors |
| 06/28/2007 | WO2007071963A2 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 06/28/2007 | WO2007071961A1 Benzamide derivatives |
| 06/28/2007 | WO2007071956A1 Novel benzamide derivatives |
| 06/28/2007 | WO2007071952A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases |
| 06/28/2007 | WO2007071753A2 S-omeprazole magnesium |
| 06/28/2007 | WO2007071752A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors |
| 06/28/2007 | WO2007071742A1 Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof |
| 06/28/2007 | WO2007071691A1 3- (4-{ [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl] 0xy} phenyl) -1-piperidinyl] carbonyl }-1-naphthalenyl) propanoic or propenoic acid as h1 and h3 receptor antagonists for the treatment of inflammatory and/or allergic disorders |
| 06/28/2007 | WO2007071639A1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists |
| 06/28/2007 | WO2007071638A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| 06/28/2007 | WO2007071576A1 New salt and polymorph of dpp-iv inhibitor |
| 06/28/2007 | WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 06/28/2007 | WO2007071444A2 Esomeprazole arginine |
| 06/28/2007 | WO2007071396A2 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 06/28/2007 | WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | WO2007071348A1 Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 06/28/2007 | WO2007071199A1 2,4-disubstituted amido-6-substituted-[1,3,5]triazine or 1,3-pyrimidine compounds, their processes for preparation, their pharmaceutical compositions and uses thereof |
| 06/28/2007 | WO2007071055A1 Compositions and methods for modulating gated ion channels |
| 06/28/2007 | WO2007071035A1 Heterocyclic amide derivatives as calcium channel blockers |
| 06/28/2007 | WO2007071023A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/28/2007 | WO2007048065A3 Pyrimidinones as casein kinase ii (ck2) modulators |
| 06/28/2007 | WO2007044085A3 Heteroaryl compounds and their uses as therapeutic agents |
| 06/28/2007 | WO2007026920A3 Amide derivatives as rock inhibitors |